Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 99 336127 036153 608161 672--
Entreprise Value (EV)1 117 650142 516167 607173 603171 309170 123
P/E ratio 285x55,2x42,2x56,8x35,2x27,8x
Yield 1,88%1,60%1,52%1,58%1,72%1,95%
Capitalization / Revenue 3,63x4,15x4,81x5,16x4,61x4,27x
EV / Revenue 4,30x4,66x5,25x5,54x4,89x4,50x
EV / EBITDA 16,8x14,5x20,5x24,7x19,2x16,5x
Price to Book 3,22x4,16x4,92x4,19x3,91x4,09x
Nbr of stocks (in thousands) 1 740 6011 756 3331 768 4561 768 845--
Reference price (USD) 57,172,386,991,491,491,4
Last update 01/24/201801/23/201901/22/202006/02/202006/02/202006/02/2020
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 27 39030 57831 90431 31835 05937 822
EBITDA1 7 0229 8338 1887 0328 90210 279
Operating profit (EBIT)1 5 9766 5557 1106 1097 9038 804
Operating Margin 21,8%21,4%22,3%19,5%22,5%23,3%
Pre-Tax Profit (EBT)1 2 2312 8734 0772 1974 0344 034
Net income1 3532 3343 6872 7744 5976 062
Net margin 1,29%7,63%11,6%8,86%13,1%16,0%
EPS2 0,201,312,061,612,603,29
Dividend per Share2 1,081,161,321,441,571,79
Last update 01/24/201801/23/201901/22/202006/02/202006/02/202006/02/2020
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 18 31415 48013 99911 9309 6378 450
Net Cash position1 ------
Leverage (Debt / EBITDA) 2,61x1,57x1,71x1,70x1,08x0,82x
Free Cash Flow1 4 4354 9064 4984 7276 2897 218
ROE (Net Profit / Equities) 17,1%16,7%18,9%13,3%16,2%18,8%
Shareholders' equity1 2 06313 97019 54920 88628 28932 208
ROA (Net Profit / Asset) 6,83%7,16%8,60%5,33%7,49%10,7%
Assets1 5 17132 62042 85452 04461 35856 521
Book Value Per Share2 17,717,417,621,823,422,3
Cash Flow per Share2 3,183,563,453,934,06-
Capex1 1 0001 3941 6381 6231 7231 823
Capex / Sales 3,65%4,56%5,13%5,18%4,91%4,82%
Last update 01/24/201801/23/201901/22/202005/22/202005/22/202005/22/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (USD)
161 672 462 796
Net sales (USD)
31 904 000 000
Number of employees
107 000
Sales / Employee (USD)
298 168
Free-Float
88,8%
Free-Float capitalization (USD)
143 518 984 345
Avg. Exchange 20 sessions (USD)
716 098 015
Average Daily Capital Traded
0,44%
EPS & Dividend